Analyst Ranking
Bottom 4%
#4703 out of 4861 analysts
Average Return
-13.13%
Win Rate
35%29 out of 82
Risk vs Reward
Poor
Good

Eric Joseph's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Revolution Medicines IncRVMD
+176.50%$21.49$59.42
2023-11-06 -
2024-11-06
Strong Buy
Tg Therapeutics IncTGTX
+173.91%$13.99$38.32
2024-04-17 -
2025-04-17
Strong Buy
Tg Therapeutics IncTGTX
+147.63%$10.12$25.06
2023-10-31 -
2024-10-31
Strong Buy
Tg Therapeutics IncTGTX
+103.76%$10.10$20.58
2023-08-06 -
2024-08-06
Strong Buy
Akero Therapeutics IncAKRO
+93.35%$15.04$29.08
2023-10-10 -
2024-10-10
Strong Buy

Eric Joseph Analyst Color

Get additional color on Eric Joseph's coverage of popular stocks

Eric Joseph's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Ptc Therapeutics IncPTCT
9Strong Buy$75.00+58.26%Maintains
21 days ago
Nurix Therapeutics IncNRIX
7Strong Buy$30.00+192.97%Maintains
3 months ago
Vir Biotechnology IncVIR
5Hold$14.00+154.55%Maintains
3 months ago
Revolution Medicines IncRVMD
6Strong Buy$71.00+93.14%Maintains
5 months ago
Tg Therapeutics IncTGTX
4Strong Buy$43.00+12.21%Maintains
5 months ago
Septerna IncSEPN
1Strong Buy$38.00+544.07%Initiates Coverage On
5 months ago
Camp4 Therapeutics CorpCAMP
1Strong Buy$23.00+1,061.62%Initiates Coverage On
6 months ago
Wave Life Sciences LtdWVE
2Strong Buy$17.00+187.16%Maintains
6 months ago
Igm Biosciences IncIGMS
7Strong Sell$9.00+637.70%Downgrades
7 months ago
Relay Therapeutics IncRLAY
5Strong Buy$21.00+680.67%Maintains
7 months ago
Novavax IncNVAX
7Strong Sell$9.00+50.00%Maintains
8 months ago
Beam Therapeutics IncBEAM
3Strong Buy$48.00+182.35%Maintains
8 months ago
Enanta Pharmaceuticals IncENTA
4Strong Sell$10.00+96.08%Maintains
8 months ago
Rocket Pharmaceuticals IncRCKT
2Strong Buy$54.00+753.08%Maintains
8 months ago
Hillevax IncHLVX
3Strong Buy$24.00+1,320.12%Maintains
a year ago
Prime Medicine IncPRME
4Strong Buy$15.00+1,109.68%Maintains
a year ago
Kymera Therapeutics IncKYMR
2Strong Buy$47.00N/AMaintains
a year ago
C4 Therapeutics IncCCCC
4Hold$6.00N/AUpgrades
a year ago
Livent CorpLTHM
2Hold$15.00N/AMaintains
a year ago
Recursion Pharmaceuticals IncRXRX
2Hold$10.00N/AMaintains
a year ago
Monte Rosa Therapeutics IncGLUE
2Strong Buy$11.00N/AMaintains
2 years ago
Akero Therapeutics IncAKRO
2Strong Buy$41.00N/AMaintains
2 years ago
Lyell Immunopharma IncLYEL
1Hold$5.00N/ADowngrades
2 years ago
Century Therapeutics IncIPSC
2Hold$5.00N/ADowngrades
2 years ago
Pliant Therapeutics IncPLRX
3Strong Buy$48.00N/AMaintains
2 years ago
Terns Pharmaceuticals IncTERN
6Hold$11.00N/AMaintains
2 years ago
Bluebird Bio IncBLUE
1Strong Buy$140.00N/AInitiates Coverage On
2 years ago
Atea Pharmaceuticals IncAVIR
4Hold$8.00N/AMaintains
2 years ago
Mirati Therapeutics IncMRTX
1Hold$65.00N/ADowngrades
2 years ago
Surrozen IncSRZN
2Strong SellN/AN/ADowngrades
2 years ago
Karyopharm Therapeutics IncKPTI
2Hold$120.00N/AUpgrades
3 years ago
Aligos Therapeutics IncALGS
2Hold$300.00N/ADowngrades
3 years ago
Omeros CorpOMER
2Strong SellN/AN/ADowngrades
4 years ago
Freeline Therapeutics Holdings PLCFRLN
2Hold$120.00N/ADowngrades
4 years ago
Verve Therapeutics IncVERV
1Hold$50.00N/AInitiates Coverage On
4 years ago
Achilles Therapeutics PLCACHL
1Strong Sell$11.00N/AInitiates Coverage On
4 years ago
Acceleron Pharma IncXLRN
1Strong Buy$153.00N/AMaintains
4 years ago
Autolus Therapeutics PLCAUTL
2Hold$9.00N/ADowngrades
4 years ago
Akebia Therapeutics IncAKBA
1Strong SellN/AN/ADowngrades
4 years ago
Urovant Sciences LtdUROV
2Hold$16.00N/ADowngrades
4 years ago
Five Prime Therapeutics IncFPRX
2Hold$14.00N/AUpgrades
4 years ago
Obseva SaOBSVF
1Hold$5.00N/ADowngrades
5 years ago
Black Diamond Therapeutics IncBDTX
1Strong Buy$42.00N/AInitiates Coverage On
5 years ago
Momenta Pharmaceuticals IncMNTA
1Strong Buy$30.00N/AUpgrades
5 years ago
Ironwood Pharmaceuticals IncIRWD
2Hold$13.00N/AUpgrades
6 years ago
Sangamo Therapeutics IncSGMO
2Hold$11.00N/AMaintains
6 years ago
Opko Health IncOPK
2Strong SellN/AN/ADowngrades
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.